common.study.topics.clinical

Advanced Therapeutics in Rheumatoid Arthritis (RA)

common.study.values.description

Advanced Therapeutics in Rheumatoid Arthritis (RA)

This study will evaluate the retention rates of two advanced therapies, Tumour Necrosis Factor (TNF) and Janus kinase inhibitor (JAK) in the treatment of adults with Rheumatoid Arthritis (RA) over a two year period. It will also examine the ability to embed a clinical trial in a clinical situation using an electronic medical record (EMR).

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Recruiting patients only common.study.methods.is-healthy-yes

Drug - Etanercept

injection

Drug - tofacitinib

tablet

participant.views.study.view.additional

participant.views.study.view.scientific-title

Advanced Therapeutics in Rheumatoid Arthritis (RA)

common.study.values.clinical-trial-id

NCT03976245

participant.views.study.view.id

ejR9ve